IMALUMAB
UNII 22F97PC79G

Substance Identification & Data

This profile provides standardized clinical and technical data for Imalumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 22F97PC79G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1430205-07-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

22F97PC79G

CAS Registry Number

1430205-07-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IMALUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C104260

National Cancer Institute reference terminology for clinical and research data.

INN ID

9961

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imalumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMALUMAB

Common Names & Synonyms

IMALUMAB [INN]

IMALUMAB [WHO-DD]

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS MIF (MACROPHAGE MIGRATION INHIBITORY FACTOR, GLYCOSYLATION-INHIBITING FACTOR, GLIF, GIF)), HOMO SAPIENS MONOCLONAL ANTIBODY